A Quality Driven Biosimilar Development
Found 5 free book(s)REPORT - Biologic Innovation, Quality & Reliability
www.amgenbiotech.com3. WHAT ARE BIOLOGICS AND BIOSIMILARS? A biologic medicine is a large molecule derived from living cells that is used to treat or prevent disease, such as a therapeutic protein, DNA vaccine, monoclonal antibody (i.e., MAB) or fusion
Investor Presentation - drreddys.com
www.drreddys.comKey strengths and capabilities Industry leading product development skills Deep market presence Early mover advantage in Biosimilars Collaboration across business units
The U.S. Biosimilars Market
www.dean.com4 The U.S. Biosimilars Market Key Biologic Sales vs. Complexity U.S. Sales, 2008 Each of the factors outlined above will have wide-reaching implications for biosimilar developers, big pharma and
Trends & Opportunities for Indian Pharma
ficci.inForeword The Indian pharmaceutical industry has contributed significantly to global healthcare by ensuring high quality, affordable and accessible medicines around the world.
Dr. Reddy’s
www.drreddys.comInvestor Presentation - 2016 Dr. Reddy’s Laboratories Ltd. 6 Executive Summary • During the last decade, our top line grew at 18% CAGR with healthy profitability, on the back of strong performance from US generics and branded formulations in Emerging markets.